Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Intuitive Surgical, Inc.(ISRG) | 226,000 | 245,000 | +19,000 | $90.19M | $108.99M | 4.63% | +$18.79M |
| Boston Scientific Corporation(BSX) | 1,956,000 | 1,170,100 | -785,900 | $133.97M | $90.11M | 3.83% | -$43.86M |
| Natera, Inc.(NTRA) | 803,300 | 766,500 | -36,800 | $73.47M | $83.00M | 3.53% | +$9.53M |
| Arvinas, Inc.(ARVN) | 2,985,190 | 2,987,845 | +2,655 | $123.23M | $79.54M | 3.38% | -$43.69M |
| Acadia Healthcare Company, Inc.(ACHC) | 1,005,000 | 1,120,000 | +115,000 | $79.62M | $75.64M | 3.21% | -$3.97M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,717,554 | 2,917,231 | +199,677 | $81.53M | $75.50M | 3.21% | -$6.03M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 2,412,500 | 3,335,000 | +922,500 | $57.42M | $68.47M | 2.91% | +$11.05M |
| Neurocrine Biosciences, Inc.(NBIX) | 536,500 | 491,000 | -45,500 | $73.99M | $67.60M | 2.87% | -$6.40M |
| Avantor, Inc.(AVTR) | 2,695,000 | 3,086,000 | +391,000 | $68.91M | $65.42M | 2.78% | -$3.49M |
| The Cigna Group(CI) | 184,500 | 184,500 | 0 | $67.01M | $60.99M | 2.59% | -$6.02M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 584,000 | 544,500 | -39,500 | $70.33M | $58.11M | 2.47% | -$12.21M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 243,000 | 222,000 | -21,000 | $36.32M | $53.95M | 2.29% | +$17.63M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 68,000 | 48,000 | -20,000 | $65.45M | $50.45M | 2.14% | -$15.00M |
| Illumina, Inc.(ILMN) | 464,100 | 478,000 | +13,900 | $63.73M | $49.89M | 2.12% | -$13.84M |
| Tenet Healthcare Corporation(THC) | 601,000 | 372,000 | -229,000 | $63.17M | $49.49M | 2.10% | -$13.68M |
| AbbVie Inc.(ABBV) | 227,000 | 277,800 | +50,800 | $41.34M | $47.65M | 2.02% | +$6.31M |
| Thermo Fisher Scientific Inc.(TMO) | 36,600 | 80,000 | +43,400 | $21.27M | $44.24M | 1.88% | +$22.97M |
| Structure Therapeutics IncADS | 864,000 | 1,075,000 | +211,000 | $37.03M | $42.22M | 1.79% | +$5.18M |
| Blueprint Medicines Corp | 426,000 | 383,000 | -43,000 | $40.41M | $41.28M | 1.75% | +$869.4K |
| CG Oncology, Inc.(CGON) | 1,454,765 | 1,296,225 | -158,540 | $63.86M | $40.92M | 1.74% | -$22.94M |
| Merck & Co., Inc.(MRK) | 502,000 | 325,000 | -177,000 | $66.24M | $40.23M | 1.71% | -$26.00M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 933,500 | 960,000 | +26,500 | $43.59M | $39.46M | 1.68% | -$4.13M |
| IDEAYA Biosciences, Inc.(IDYA) | 799,700 | 1,117,000 | +317,300 | $35.09M | $39.22M | 1.67% | +$4.13M |
| Danaher Corporation(DHR) | 143,800 | 150,000 | +6,200 | $35.91M | $37.48M | 1.59% | +$1.57M |
| Janux Therapeutics, Inc.(JANX) | 384,245 | 840,219 | +455,974 | $14.47M | $35.20M | 1.50% | +$20.73M |
| United Therapeutics Corporation(UTHR) | 217,000 | 110,000 | -107,000 | $49.85M | $35.04M | 1.49% | -$14.81M |
| Incyte Corporation(INCY) | 0 | 529,000 | +529,000 | $0 | $32.07M | 1.36% | +$32.07M |
| Surgery Partners, Inc.(SGRY) | 1,445,000 | 1,306,477 | -138,523 | $43.10M | $31.08M | 1.32% | -$12.02M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 3,037,668 | +3,037,668 | $0 | $30.29M | 1.29% | +$30.29M |
| Axsome Therapeutics, Inc.(AXSM) | 431,000 | 376,000 | -55,000 | $34.39M | $30.27M | 1.29% | -$4.13M |
| Xenon Pharmaceuticals Inc.(XENE) | 710,000 | 754,000 | +44,000 | $30.57M | $29.40M | 1.25% | -$1.17M |
| DexCom, Inc.(DXCM) | 176,900 | 259,000 | +82,100 | $24.54M | $29.37M | 1.25% | +$4.83M |
| Revolution Medicines, Inc.(RVMD) | 635,000 | 755,000 | +120,000 | $20.47M | $29.30M | 1.25% | +$8.84M |
| Insmed Incorporated(INSM) | 0 | 430,000 | +430,000 | $0 | $28.81M | 1.22% | +$28.81M |
| Intra-Cellular Therapies Inc | 600,000 | 400,000 | -200,000 | $41.52M | $27.40M | 1.16% | -$14.12M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 1,559,826 | +1,559,826 | $0 | $27.20M | 1.16% | +$27.20M |
| Glaukos Corporation(GKOS) | 224,000 | 224,000 | 0 | $21.12M | $26.51M | 1.13% | +$5.39M |
| Neurogene Inc.(NGNE) | 465,237 | 727,537 | +262,300 | $23.68M | $26.48M | 1.12% | +$2.79M |
| argenx SEADR(ARGX) | 0 | 60,500 | +60,500 | $0 | $26.02M | 1.11% | +$26.02M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,142,850 | 731,104 | -411,746 | $28.71M | $25.00M | 1.06% | -$3.71M |
| Establishment Labs Holdings Inc.(ESTA) | 225,000 | 531,000 | +306,000 | $11.45M | $24.13M | 1.03% | +$12.68M |
| Immunovant, Inc.(IMVT) | 505,000 | 908,000 | +403,000 | $16.32M | $23.97M | 1.02% | +$7.65M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,025,000 | 1,100,000 | +75,000 | $27.61M | $23.68M | 1.01% | -$3.93M |
| Lantheus Holdings, Inc.(LNTH) | 480,000 | 290,000 | -190,000 | $29.88M | $23.28M | 0.99% | -$6.59M |
| Vaxcyte, Inc.(PCVX) | 284,000 | 284,000 | 0 | $19.40M | $21.44M | 0.91% | +$2.04M |
| Apogee Therapeutics Inc | 384,893 | 487,000 | +102,107 | $25.58M | $19.16M | 0.81% | -$6.41M |
| Jasper Therapeutics, Inc.(JSPR) | 760,000 | 782,000 | +22,000 | $22.31M | $17.75M | 0.75% | -$4.56M |
| Neumora Therapeutics, Inc.(NMRA) | 1,800,000 | 1,800,000 | 0 | $24.75M | $17.69M | 0.75% | -$7.06M |
| Legend Biotech CorporationADS(LEGN) | 668,300 | 398,000 | -270,300 | $37.48M | $17.63M | 0.75% | -$19.86M |
| Gilead Sciences, Inc.(GILD) | 0 | 255,000 | +255,000 | $0 | $17.50M | 0.74% | +$17.50M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,735,000 | 1,620,000 | -115,000 | $18.43M | $16.69M | 0.71% | -$1.74M |
| AstraZeneca PLCADR(AZN) | 160,000 | 205,000 | +45,000 | $10.84M | $15.99M | 0.68% | +$5.15M |
| Keros Therapeutics, Inc.(KROS) | 209,700 | 343,200 | +133,500 | $13.88M | $15.68M | 0.67% | +$1.80M |
| Biohaven Ltd.(BHVN) | 75,000 | 450,000 | +375,000 | $4.10M | $15.62M | 0.66% | +$11.52M |
| SanofiADR(SNY) | 0 | 315,000 | +315,000 | $0 | $15.28M | 0.65% | +$15.28M |
| REGENXBIO Inc.(RGNX) | 1,300,064 | 1,300,064 | 0 | $27.39M | $15.21M | 0.65% | -$12.18M |
| Context Therapeutics Inc.(CNTX) | 0 | 7,419,355 | +7,419,355 | $0 | $14.88M | 0.63% | +$14.88M |
| Endeavour Silver Corp.(EXK) | 0 | 338,500 | +338,500 | $0 | $14.30M | 0.61% | +$14.30M |
| Privia Health Group, Inc.(PRVA) | 764,200 | 764,200 | 0 | $14.97M | $13.28M | 0.56% | -$1.69M |
| Newamsterdam Pharma Company ORDINARY SHARES | 475,000 | 559,300 | +84,300 | $11.23M | $10.74M | 0.46% | -$489.6K |
| Immunome, Inc.(IMNM) | 873,891 | 873,891 | 0 | $21.57M | $10.57M | 0.45% | -$10.99M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,902,972 | 0 | $11.75M | $9.88M | 0.42% | -$1.87M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 215,600 | +215,600 | $0 | $9.76M | 0.41% | +$9.76M |
| Cybin D/B/A Helus Pharma(HELP) | 34,884,000 | 34,884,000 | 0 | $14.42M | $9.45M | 0.40% | -$4.97M |
| Syros Pharmaceuticals Inc | 1,673,538 | 1,673,538 | 0 | $8.95M | $8.64M | 0.37% | -$318.0K |
| Cogent Biosciences, Inc.(COGT) | 445,706 | 1,000,706 | +555,000 | $3.00M | $8.44M | 0.36% | +$5.44M |
| Immunocore Holdings plcADS(IMCR) | 286,400 | 200,000 | -86,400 | $18.62M | $6.78M | 0.29% | -$11.84M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 373,000 | +373,000 | $0 | $5.96M | 0.25% | +$5.96M |
| UiPath, Inc.CL A(PATH) | 0 | 362,000 | +362,000 | $0 | $4.59M | 0.20% | +$4.59M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 195,000 | +195,000 | $0 | $4.58M | 0.19% | +$4.58M |
| Immatics N.V.SHS(IMTX) | 0 | 393,100 | +393,100 | $0 | $4.57M | 0.19% | +$4.57M |
| Ionis Pharmaceuticals, Inc.(IONS) | 130,000 | 93,000 | -37,000 | $5.64M | $4.43M | 0.19% | -$1.20M |
| Arca Biopharma Inc | 0 | 1,000,000 | +1,000,000 | $0 | $3.83M | 0.16% | +$3.83M |
| Editas Medicine, Inc.(EDIT) | 0 | 816,000 | +816,000 | $0 | $3.81M | 0.16% | +$3.81M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 170,000 | +170,000 | $0 | $3.80M | 0.16% | +$3.80M |
| Collegium Pharmaceutical, Inc.(COLL) | 361,400 | 117,000 | -244,400 | $14.03M | $3.77M | 0.16% | -$10.26M |
| Prime Medicine, Inc.(PRME) | 1,990,000 | 694,000 | -1,296,000 | $13.93M | $3.57M | 0.15% | -$10.36M |
| AC Immune SASHS(ACIU) | 4,470,000 | 825,000 | -3,645,000 | $13.23M | $3.29M | 0.14% | -$9.94M |
| Kezar Life Sciences Inc | 5,026,000 | 5,026,000 | 0 | $4.53M | $3.02M | 0.13% | -$1.52M |
| SCYNEXIS, Inc.(SCYX) | 1,448,728 | 1,448,728 | 0 | $2.13M | $2.90M | 0.12% | +$767.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 8,298,570 | 2,018,500 | -6,280,070 | $12.53M | $1.75M | 0.07% | -$10.78M |
| Wave Life Sciences, Inc.SHS(WVE) | 0 | 350,000 | +350,000 | $0 | $1.75M | 0.07% | +$1.75M |
| Hyperfine, Inc.CL A(HYPR) | 1,188,178 | 1,188,178 | 0 | $1.19M | $1.01M | 0.04% | -$178.2K |
| Caremax IncCL A | 21,200 | 21,200 | 0 | $102.2K | $59.1K | 0.00% | -$43.0K |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 89,543 | 12,136 | -77,407 | $27.1K | $1.9K | 0.00% | -$25.1K |
| Acadia Pharmaceuticals Inc | 588,500 | 0 | -588,500 | $10.88M | $0 | — | -$10.88M |
| Align Technology Inc | 189,000 | 0 | -189,000 | $61.98M | $0 | — | -$61.98M |
| Alpine Immune Sciences Inc | 1,174,700 | 0 | -1,174,700 | $46.57M | $0 | — | -$46.57M |
| An2 Therapeutics Inc | 1,150,000 | 0 | -1,150,000 | $3.74M | $0 | — | -$3.74M |
| Astria Therapeutics Inc | 982,000 | 0 | -982,000 | $13.82M | $0 | — | -$13.82M |
| Caribou Biosciences, Inc.(CRBU) | 5,785,352 | 0 | -5,785,352 | $29.74M | $0 | — | -$29.74M |
| Century Therapeutics, Inc.(IPSC) | 1,221,555 | 0 | -1,221,555 | $5.11M | $0 | — | -$5.11M |
| CVS Health Corporation(CVS) | 545,000 | 0 | -545,000 | $43.47M | $0 | — | -$43.47M |
| Cytokinetics, Incorporated(CYTK) | 166,000 | 0 | -166,000 | $11.64M | $0 | — | -$11.64M |
| Eli Lilly and Company(LLY) | 70,000 | 0 | -70,000 | $54.46M | $0 | — | -$54.46M |
| Emergent BioSolutions Inc.(EBS) | 1,908,000 | 0 | -1,908,000 | $4.83M | $0 | — | -$4.83M |
| Fusion Pharmaceuticals Inc | 6,500,328 | 0 | -6,500,328 | $138.59M | $0 | — | -$138.59M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 3,000,000 | 0 | -3,000,000 | $3.48M | $0 | — | -$3.48M |
| Kodiak Sciences Inc.(KOD) | 300,000 | 0 | -300,000 | $1.58M | $0 | — | -$1.58M |
| Kyverna Therapeutics, Inc.(KYTX) | 202,333 | 0 | -202,333 | $5.03M | $0 | — | -$5.03M |